Mbeki claims that AZT is dangerousBMJ 1999; 319 doi: https://doi.org/10.1136/bmj.319.7224.1522g (Published 11 December 1999) Cite this as: BMJ 1999;319:1522
- Pat Sidley
The South African president, Thabo Mbeki, and the minister of health, Dr Manto Tshabalala-Msimang, have deepened a political storm about the well known antiviral drug zidovudine (AZT), developed and marketed by Glaxo-Wellcome.
The drug, which went through South Africa's drug regulatory system a decade ago, has been used since its registration with similar results and side effects to those experienced in other countries.
But within the last month, Mr Mbeki shocked the community lobbying for better prevention and treatment of HIV infection and AIDS by stating unequivocally that AZT was dangerous and asking the minister of health to launch an inquiry into …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial